Hair-Loss Drug Impedes Prostate Cancer Detection in Middle-Aged Men

Armen Hareyan's picture
Advertisement

Researchers at Brigham and Women's Hospital (BWH) have found that the prostate specific antigen (PSA) cancer screening test is falsely lowered by a factor of two in middle-aged men who have taken Propecia, a hair-loss drug used by more than four million men worldwide, for one year.

Advertisement